Call Options

15 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$63.15 - $72.88 $315,750 - $364,400
5,000 Added 5000.0%
5,100 $349,000
Q1 2024

May 06, 2024

BUY
$71.58 - $87.29 $7,158 - $8,729
100 New
100 $7,000
Q1 2023

May 11, 2023

BUY
$77.31 - $88.08 $7,731 - $8,808
100 New
100 $8,000
Q2 2022

Aug 10, 2022

BUY
$57.72 - $65.01 $5,714 - $6,435
99 Added 9900.0%
100 $1,000
Q1 2022

May 12, 2022

SELL
$57.92 - $72.58 $5,734 - $7,185
-99 Reduced 99.0%
1 $0
Q2 2021

Aug 06, 2021

SELL
$63.47 - $69.35 $4,062 - $4,438
-64 Reduced 39.02%
100 $1,000
Q4 2020

Feb 10, 2021

SELL
$56.65 - $64.55 $1.01 Million - $1.15 Million
-17,836 Reduced 99.09%
164 $53,000
Q3 2020

Nov 13, 2020

BUY
$62.1 - $78.08 $1.06 Million - $1.33 Million
17,000 Added 1700.0%
18,000 $13,000
Q1 2020

May 21, 2020

SELL
$62.63 - $80.22 $62,630 - $80,220
-1,000 Reduced 50.0%
1,000 $8,000
Q2 2019

Aug 13, 2019

SELL
$61.87 - $69.38 $866,180 - $971,319
-14,000 Reduced 87.5%
2,000 $3,000
Q3 2018

Nov 09, 2018

BUY
$71.28 - $78.92 $997,920 - $1.1 Million
14,000 Added 700.0%
16,000 $46,000
Q1 2018

May 15, 2018

SELL
$72.84 - $88.8 $473,460 - $577,200
-6,500 Reduced 76.47%
2,000 $1,000
Q4 2017

Feb 14, 2018

SELL
$71.15 - $83.52 $476,705 - $559,584
-6,700 Reduced 44.08%
8,500 $2,000
Q3 2017

Nov 14, 2017

SELL
$72.11 - $85.47 $93,743 - $111,111
-1,300 Reduced 7.88%
15,200 $72,000
Q2 2017

Aug 14, 2017

BUY
N/A
16,500
16,500 $56,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $111B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.